


To provide long-term capital growth and income.
| Name | % Net Assets |
|---|---|
| BP | 2.8% |
| Royal Dutch Shell B | 2.3% |
| HSBC Holdings PLC (UK Reg) | 2.2% |
| Vodafone Group | 1.9% |
| GlaxoSmithKline | 1.4% |
| 4¾% Treasury Stock 2015 | 1.3% |
| AstraZeneca | 1.2% |
| BHP Billiton | 1.1% |
| 5¼% Treasury Gilt 2012 | 1.1% |
| Tesco | 1.0% |
| Key | % Net Assets |
|---|---|
| 2.8% | |
| 2.3% | |
| 2.2% | |
| 1.9% | |
| 90.8% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 13/11/1998 |
|---|---|
| Fund Manager | Steve Cleal |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research